https://adisinsight.springer.com/trials/700364445?error=cookies_not_supported&code=7c11efcb-5593-4bf4-8046-c2f0d3769084
A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib...
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in